TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 6 | -1 | 3 | 14 | 64 | 30 | 39 | 25 | 
| P | %wins | 50 | 60 | 80 | 100 | 40 | 50 | 63 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/12/17 08:09  | 5/10/17  | SPAR | Spartan Motors Inc | MI | Auto | Auto | Motor Vehicles & Passenger Ca | Current Richard R | MI | D | P | 46 | 9.00 | 2 | 5 | 6 | 90 | D | 123 | 56 | 18 | 14 | 19 | 15 | 7 | 3 | -1 | ||||||
5/10/16 11:18  | 5/9/16  | SPAR | Spartan Motors Inc | MI | Auto | Auto | Motor Vehicles & Passenger Ca | Current Richard R | MI | D | P | 17 | 5.60 | 1 | 3 | 4 | 75 | D | 24 | 35 | 46 | 82 | 40 | 16 | 15 | 11 | 6 | 9 | 14 | 62 | 47 | ||
5/14/15 12:44  | 5/13/15  | SPAR | Spartan Motors Inc | MI | Auto | Auto | Motor Vehicles & Passenger Ca | Current Richard R | MI | D | P | 25 | 4.41 | 1 | 6 | 11 | 60 | D | -18 | -13 | -19 | -17 | -10 | -11 | -5 | 5 | 3 | -4 | 8 | 9 | -11 | 41 | |
2/24/09 10:30  | 2/23/09  | SPAR | Spartan Motors Inc | MI | Auto | Auto | Motor Vehicles & Passenger Ca | Current Richard R | MI | D | P | 11 | 2.46 | 1 | 5 | 900 | 5 | -11 | 9 | 49 | 238 | 138 | 130 | ||||||||||
11/20/07 20:50  | 11/19/07  | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Current Richard R | O | VP,CFO | P | 3 | 25.91 | 3 | 0 | 0 | 48 | D | 94 | 85 | 41 | 25 | 1 | -4 | -6 | -8 | -1 | 4 | -2 | 6 | -5 | -10 | |
1/11/06 15:01  | 1/9/06  | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Current Richard R | O | VP CFO | P | 2 | 20.45 | 2 | 0 | 0 | 22 | 0 | -2 | 0 | 5 | -19 | -5 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |